SmartNuclide Biopharma
8 clinical trials · Sponsor
◉ Watch SmartNuclide Biopharma
| Record | Firm | Date |
|---|---|---|
| A Preliminary Efficacy of SNA028 in Patients With Advanced Colorectal Cancer Positive for GPA33 (NCT07590856) | SmartNuclide Biopharma | 2026-05-01 |
| A IIT Study of 177Lu-DOTA-SNA040 (NCT07595237) | SmartNuclide Biopharma | 2025-11-01 |
| Phase IIT Trial of SNA009 (NCT07597759) | SmartNuclide Biopharma | 2025-10-30 |
| Preliminary Trial of SNA014 for Pancreatic Cancer (NCT07597772) | SmartNuclide Biopharma | 2025-10-01 |
| Phase IIT Trial of SNA014 (NCT06646783) | SmartNuclide Biopharma | 2024-10-20 |
| Phase I Clinical Trial of 68Ga-NOTA-SNA002 (NCT05989997) | SmartNuclide Biopharma | 2023-11-01 |
| [68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors (NCT05490264) | SmartNuclide Biopharma | 2022-10-18 |
| A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors (NCT05126927) | SmartNuclide Biopharma | 2021-11-02 |
Track SmartNuclide Biopharma automatically
Every clearance here is in the API, with alerts when new ones post.